- Our Doctors
- Dr Jeremy de Leon
Dr Jeremy de Leon
BSc (Bioinformatics), M.B.B.S (Honours), FRANZCR, Radiation Oncologist
Languages spoken
English
Overview
Centres
Clinical interests
Clinical interests in upper gastrointestinal (GI), urogenital, lung cancers and advanced treatment technology including MR-Linac.
Jeremy completed a Bachelor of Science in Bioinformatics prior to graduating from a Bachelor of Medicine with Honours in 2006 from the University of Sydney. He completed his radiation oncology training at Liverpool, Campbelltown, and Canberra Hospitals, followed by a Fellowship at the Royal North Shore Hospital.
Jeremy subsequently took up a staff specialist position at the Illawarra and Shoalhaven Cancer Therapy Centres, prior to joining GenesisCare, Darlinghurst (based at the St Vincent’s Hospital campus) in Sydney, as the Head of the MR-Linac program.
Jeremy's clinical interests are upper GI, urogenital, lung cancers and stereotactic treatments. He is the most experienced doctor in Australia utilising the MR-Linac technology to treat a range of tumour types.
Jeremy is an active clinician researcher and investigator in international and national clinical trials. The Australian MR-Linac team has published multiple peer reviewed articles about improving treatment efficiency and clinical outcomes in different tumour types. In addition, Jeremy has presented at both international and national conferences on various topics about he and the team’s experience using MR-Linac technology.
Beyond his clinical responsibilities, he is active in professional organisations, serving on the TROG Adaptive Radiotherapy subcommittee and the Radiation Oncology Alliance working group on Adaptive Radiation Therapy. Additionally, he is an executive member of the NSW Cancer Institute Prostate Cancer Outcomes Registry and the RANZCR Faculty of Radiation Oncology Genito-Urinary Group.
Outside of work, Jeremy enjoys time with his family, which usually revolved around food.
Research interests
- Radiation therapy technologies including MR-Linac, stereotactic radiation therapy, and biomarkers.
Professional memberships
- FRANZCR
- ANZUP
- FROLIC
- Breast Cancers Trial Group
- AGITG
- ALTG
Publications
- de Leon J, Jameson MG, Rivest-Henault D, Keats S, Rai R, Arumugam S, Wilton L, Ngo D, Liney G, Moses D, Dowling J, Martin J, Sidhom M Reduced motion and improved rectal dosimetry through endorectal immobilization for prostate stereotactic body radiotherapy. Br J Radiol. 2019 Jun;92(1098)
- de Leon J, Kneebone A, Gebski V, Cross S, Do V, Hayden A, Ngo D, Sidhom M, Turner S. Long-term outcomes in 1121 Australian prostate cancer patients treated with definitive radiotherapy. J Med Imaging Radiat Oncol. 2019 Feb;63(1):116-123
- de Leon J, Jameson MG, Windsor AA, Cloak K, Keats S, Vial P, Holloway L, Metcalfe P & Sidhom M: Superior target volume and organ stability with the use of Endorectal Balloons in Post Prostatectomy Radiotherapy. J Med Imaging Radiat Oncol. 2015 Aug;59(4):507-13.
- Jameson MG, de Leon J, Windsor AA, Cloak K, Keats S, Dowling JA, Chandra SS, Vial P, Sidhom M, Holloway L & Metcalfe P. Endorectal balloons in the post prostatectomy setting: do gains in stability lead to more predictable dosimetry? Radiother Oncol. 2013 Dec;109(3):493-7
- Roach D, Holloway LC, Jameson MG, Dowling JA, Kennedy A, Greer PB, Krawiec M, Rai R, Denham J, de Leon J, Lim K, Berry ME, White RT, Bydder SA, Tan HT, Croker JD, McGrath A, Matthews J, Smeenk RJ, Ebert MA. Multi-observer contouring of male pelvic anatomy: Highly variable agreement across conventional and emerging structures of interest. J Med Imaging Radiat Oncol. 2019 Apr;63(2):264-271